サンプル依頼リスト カート
  • English
  • Korean
表紙：がん登録ソフトウェアの世界市場：2023-2030年
市場調査レポート
商品コード
1380247

がん登録ソフトウェアの世界市場：2023-2030年

Global Cancer Registry Software Market 2023-2030
出版日: | 発行: Orion Market Research | ページ情報: 英文 240 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
がん登録ソフトウェアの世界市場：2023-2030年
出版日: 2023年09月25日
発行: Orion Market Research
ページ情報: 英文 240 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のがん登録ソフトウェア市場は、予測期間中にCAGR 10.5%の大幅な成長が見込まれています。がんの有病率の増加、医療の質の向上、主なプレイヤーによる最近の市場開拓とともにヘルスケアコストの削減が、世界のがん登録ソフトウェア市場の成長を促進しています。世界保健機関（WHO）によると、がんは世界の主要な死亡原因であり、2020年の死亡者数は約1,000万人、死傷者の約6人に1人を占める。最も一般的ながんは、乳がん、肺がん、結腸直腸がん、前立腺がんなどです。さらに、2021年7月に更新された国際がん研究機関（IARC）の推計によると、2040年までに、がんの世界の負担は、世界で新たに2,750万人のがん患者と1,630万人の死傷者に増加すると予想されています。このような高負担は、がんの有病率や治療に関する動向を特定する上で大きな利益をもたらすため、がん登録ソフトウェアの需要を高めると思われます。

高いがん罹患率とがん登録ソフトウェアの急速な普及により、市場は成長する可能性が高いです。しかし、患者データのプライバシーやセキュリティに対する懸念が市場成長の抑制要因となると思われます。しかし、このソフトウェアの普及に対する政府の関与の高まりは、世界のがん登録ソフトウェア市場の成長に有利な機会を提供すると思われます。

セグメント別展望

病院・医療現場ががん登録ソフトウェアの世界市場でかなりのシェアを占める

2022年の世界のがん登録ソフトウェア市場では、病院・診療所がかなりのシェアを占めました。病院におけるがん関連の処置件数の増加が、この地域市場の高いシェアに寄与しています。患者は一次医療センターとして病院を頼りにしており、これがこの市場セグメントの成長を牽引しているとみられます。スリランカは世界保健機関（WHO）の東南アジア地域加盟国のひとつであり、国際がん研究機関（IARC）およびインド・ムンバイのタタ記念センターを拠点とするIARC地域ハブから、がん登録に関する技術支援を受けています。

がん登録記録のデータ管理については、スリランカ全国がん登録（SLNCR）はIARCが開発したオープンソースの登録ソフトウェアツールCanReg5を使用しています。SLNCRは全国にある25のセンターからデータを受け取っています。地区総合病院（アビサウェラ）、州総合病院（バドゥラ）、地区総合病院（チラウ）、教育病院（カルタラム）、地区総合病院、総合病院（ヴァヴニヤ）、Apeksha病院（国立がん研究所）が、現在がん登録ソフトウェアを使用しているスリランカの主な病院です。

地域別展望

世界のがん登録ソフトウェア市場は、北米（米国とカナダ）、欧州（イタリア、スペイン、ドイツ、フランス、その他）、アジア太平洋（インド、中国、日本、韓国、その他）、世界のその他の地域（中東とアフリカ、ラテンアメリカ）の地域別にさらに細分化されています。

アジア太平洋地域が世界のがん登録ソフトウェア市場で最も高い成長を示す

同地域の成長は、ヘルスケア分野での技術導入の増加に起因します。また、この地域ではがんの症例が増加しており、より良い治療のためにがんのパターンを特定するためのがん登録ソフトウェアの採用が促進されています。Indian Council of Medical Research-National Cancer Registry Programme（ICMR-NCRP）によると、政府は2022年の1,770万米ドルから2025年には1,900万米ドルに増加すると議会に報告しています。例えば、インド政府の公共政策シンクタンクであるNITI Aayogは、バイオテクノロジー省と共同で画像バイオバンクの構築を目指しており、20,000人以上の患者プロファイルのがん関連の病理学的画像と放射線学的画像のデータベースを作成する予定です。このような画像は、がん登録のための巨大なデータベースを構築し、地域市場の成長を促進しています。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • IBM Corp.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Siemens Healthineers
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • McKesson Corp.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • がん登録ソフトウェアの世界市場：データベースタイプ別
    • 商用データベース
    • 公開データベース
  • がん登録ソフトウェアの世界市場：展開モデル別
    • クラウドベース
    • オンプレミス
  • がん登録ソフトウェアの世界市場：エンドユーザー産業別
    • 政府およびサードパーティ
    • 民間企業
    • 病院および診療所
    • その他

第5章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • C/NET Solutions
  • Conduent, Inc.
  • Electa
  • Electronic Registry System, Inc.
  • Epic Systems
  • ERS, Inc.
  • himagine solutions
  • Inspirata, Inc.
  • NeuralFrame, Inc.
  • Onco, Inc.
  • Ordinal Data Inc
  • Redsson, Ltd.,
  • Rocky Mountain Cancer Data Systems
図表

LIST OF TABLES

  • 1. GLOBAL CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DATABASE TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL CANCER REGISTRY COMMERCIAL DATABASE SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL CANCER REGISTRY PUBLIC DATABASE SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT MODEL, 2022-2030 ($ MILLION)
  • 5. GLOBAL CLOUD BASED CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL ON-PREMISES CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER INDUSTRY, 2022-2030 ($ MILLION)
  • 8. GLOBAL CANCER REGISTRY SOFTWARE FOR GOVERNMENT & THIRD PARTY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL CANCER REGISTRY SOFTWARE FOR HEALTHCARE & LIFESCIENCES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL CANCER REGISTRY SOFTWARE FOR HOSPITAL & MEDICAL PRACTICE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL CANCER REGISTRY SOFTWARE FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. NORTH AMERICAN CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DATABASE TYPE, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT MODEL, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER INDUSTRY, 2022-2030 ($ MILLION)
  • 17. EUROPEAN CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 18. EUROPEAN CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DATABASE TYPE, 2022-2030 ($ MILLION)
  • 19. EUROPEAN CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT MODEL, 2022-2030 ($ MILLION)
  • 20. EUROPEAN CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER INDUSTRY, 2022-2030 ($ MILLION)
  • 21. ASIA-PACIFIC CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 22. ASIA-PACIFIC CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DATABASE TYPE, 2022-2030 ($ MILLION)
  • 23. ASIA-PACIFIC CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT MODEL, 2022-2030 ($ MILLION)
  • 24. ASIA-PACIFIC CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER INDUSTRY, 2022-2030 ($ MILLION)
  • 25. REST OF THE WORLD CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DATABASE TYPE, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT MODEL, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER INDUSTRY, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL CANCER REGISTRY SOFTWARE MARKET SHARE BY DATABASE TYPE, 2022 VS 2030(%)
  • 2. GLOBAL CANCER REGISTRY SOFTWARE MARKET SHARE BY DEPLOYMENT MODEL, 2022 VS 2030(%)
  • 3. GLOBAL CANCER REGISTRY SOFTWARE MARKET SHARE BY END-USER INDUSTRY, 2022 VS 2030(%)
  • 4. GLOBAL CANCER REGISTRY COMMERCIAL DATABASE MARKET SHARE BY REGION, 2022 VS 2030(%)
  • 5. GLOBAL CANCER REGISTRY PUBLIC DATABASE MARKET SHARE BY REGION, 2022 VS 2030(%)
  • 6. GLOBAL CLOUD BASED CANCER REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030(%)
  • 7. GLOBAL ON-PREMISES CANCER REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030(%)
  • 8. GLOBAL CANCER REGISTRY SOFTWARE FOR GOVERNMENT & THIRD PARTY MARKET SHARE BY REGION, 2022 VS 2030(%)
  • 9. GLOBAL CANCER REGISTRY SOFTWARE FOR HEALTHCARE & LIFESCIENCES MARKET SHARE BY REGION, 2022 VS 2030(%)
  • 10. GLOBAL CANCER REGISTRY SOFTWARE FOR HOSPITAL & MEDICAL PRACTICE MARKET SHARE BY REGION, 2022 VS 2030(%)
  • 11. GLOBAL CANCER REGISTRY SOFTWARE FOR OTHERS MARKET SHARE BY REGION, 2022 VS 2030(%)
  • 12. GLOBAL CANCER REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030(%)
  • 13. US CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. CANADA CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. UK CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. FRANCE CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. GERMANY CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. ITALY CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. SPAIN CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. REST OF EUROPE CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. INDIA CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. CHINA CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. JAPAN CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. SOUTH KOREA CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. REST OF ASIA-PACIFIC CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. LATIN AMERICA CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. MIDDLE EAST AND AFRICA CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027748

Title: Global Cancer Registry Software Market Size, Share & Trends Analysis Report, By Deployment Model (On-Premise, Cloud-based), By Database Type (Commercial Database, Public Database), By End-User Industry (Government & Third Party, Private Payers, Hospital & Medical Practice, Others)Forecast Period (2023-2030).

Global cancer registry software market is anticipated to grow at a significant CAGR of 10.5% during the forecast period. The increasing prevalence of cancer, improving quality of care, and reducing healthcare costs along with recent developments by key players are driving the growth of the global cancer registry software market. According to the World Health Organization, Cancer was a leading cause of mortality worldwide, accounting for nearly 10 million mortalities in 2020, or nearly one in six casualties. The most common cancers include breast, lung, colon rectum, and prostate cancers. Additionally, according to estimates from the International Agency for Research on Cancer (IARC) updates from July 2021, by 2040, the global burden of cancers is expected to grow to 27.5 million new cancer cases and 16.3 million casualties globally. Such high burdens will increase the demand for cancer registry software as it would provide significant benefits in identifying the trend related to the prevalence and treatment of cancer.

With high cancer prevalence and rapid adoption of cancer registry software, the market is likely to grow. However, privacy and security concerns for patient data will be a restraint in the market growth. However, the growing involvement of the government in the promotion of this software is likely to offer lucrative opportunities for the growth of the global cancer registry software market.

Segmental Outlook

The global cancer registry software market is segmented based on deployment model, database type, and end-user industry. Based on the deployment model, the market is segmented into cloud-based and on-premises. Based on database type, the market is segmented into commercial databases and public databases. Based on the end-user industry, the market is segmented into government & third party, private payers, hospital & medical practice, and others.

Hospital and Medical Practice Held a Considerable Share in the Global Cancer Registry Software Market

Hospital & medical practice held a considerable share of the global cancer registry software market in 2022. The rising number of cancer-related procedures in hospitals is contributing to the high share of the regional market. Patients have been relying on hospitals as primary care centers, which is likely to drive the growth of this market segment. Sri Lanka is one of the Member States of the World Health Organization's South-East Asia Region and receives technical support for cancer registration from the International Agency for Research on Cancer (IARC), and the IARC Regional Hub based at the Tata Memorial Centre in Mumbai, India.

For data management of cancer registry records, the Sri Lanka National Cancer Registry (SLNCR) uses the open-source registry software tool, CanReg5, as developed by IARC. The SLNCR has received data from 25 centers located across the country. District General Hospital, Avissawella, Provincial General Hospital, Badulla, District General Hospital, Chilaw, Teaching Hospital, Kalutaram, District General Hospital, General Hospital, Vavuniya, and Apeksha Hospital (National Cancer Institute) are the major Sri Lankan Hospitals that are currently using cancer registry software.

Regional Outlook

The global cancer registry software market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America).

Asia-Pacific to exhibit Highest Growth in the Global Cancer registry software Market

Regional growth is attributed to an increasing adoption of technology in the healthcare sector. Also increasing cases of cancer in the region is promoting the adoption of cancer registry software to identify the pattern of cancer for its better treatment. According to the Indian Council of Medical Research-National Cancer Registry Programme (ICMR-NCRP), the government informed Parliament the number of cancer cases in the country is projected to go up from $17.7 million in 2022 to $19.0 million in 2025. For instance, NITI Aayog, the public policy think tank of the Indian Government, aims to build an Imaging Biobank in association with the Department of Biotechnology, wherein it will create a database of cancer-related pathology and radiology images of more than 20,000 profiles of patients. Such images are creating a huge database for cancer registries; thereby driving the regional market growth.

Market Players Outlook

The major companies serving the global cancer registry software market include: IBM Corp., Elekta, McKesson Corp., Siemens Healthineers, and Epic Systems among others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in September 2022, Electronic Registry Systems (ERS) Inc. and Nursenav Inc., an oncology navigation software, partnered to integrate their flagship software solutions, CRStar and CONNECT. This integration leverages cancer registry workflows and data collection to support services provided by oncology navigation. The integration between CRStar and CONNECT supports the creation of survivorship care plans by transmitting the diagnosis and treatment data directly into the patient's plan in CONNECT.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global cancer registry software market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. IBM Corp.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Siemens Healthineers
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. McKesson Corp.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Cancer Registry Software Market by Database Type
    • 4.1.1. Commercial Database
    • 4.1.2. Public Database
  • 4.2. Global Cancer Registry Software Market by Deployment Model
    • 4.2.1. Cloud Based
    • 4.2.2. On-Premises
  • 4.3. Global Cancer Registry Software Market by End-User Industry
    • 4.3.1. Government & Third Party
    • 4.3.2. Private Players
    • 4.3.3. Hospital & Medical Practice
    • 4.3.4. Others

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. C/NET Solutions
  • 6.2. Conduent, Inc.
  • 6.3. Electa
  • 6.4. Electronic Registry System, Inc.
  • 6.5. Epic Systems
  • 6.6. ERS, Inc.
  • 6.7. himagine solutions
  • 6.8. Inspirata, Inc.
  • 6.9. NeuralFrame, Inc.
  • 6.10. Onco, Inc.
  • 6.11. Ordinal Data Inc
  • 6.12. Redsson, Ltd.,
  • 6.13. Rocky Mountain Cancer Data Systems